Lecanemab Phase 3 Clarity Core Study Primary Completion

634
days
6
hours
42
minutes
18
seconds
Time since Thursday, September 15, 2022 at 7:30:00 pm (Tokyo time)

NOTE: Message provided by user. Create your own countdown

Related Links